{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:43:57Z","timestamp":1761237837466},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T00:00:00Z","timestamp":1316217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00198-011-1789-5","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T20:37:25Z","timestamp":1316205445000},"page":"2027-2035","source":"Crossref","is-referenced-by-count":30,"title":["Serum adiponectin and bone mineral density in male hemodialysis patients"],"prefix":"10.1007","volume":"23","author":[{"given":"S.","family":"Okuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Norimine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tsuboniwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kagitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. K.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,17]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0026-0495(03)00195-1","volume":"52","author":"T Yatagai","year":"2003","unstructured":"Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S (2003) Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52:1274\u20131278","journal-title":"Metabolism"},{"key":"1789_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","volume":"360","author":"RS Lindsay","year":"2002","unstructured":"Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57\u201358","journal-title":"Lancet"},{"key":"1789_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79\u201383","journal-title":"Biochem Biophys Res Commun"},{"key":"1789_CR4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595\u20131599","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1789_CR5","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","volume":"100","author":"N Ouchi","year":"1999","unstructured":"Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473\u20132476","journal-title":"Circulation"},{"key":"1789_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2183\/pjab.86.131","volume":"86","author":"Y Matsuzawa","year":"2010","unstructured":"Matsuzawa Y (2010) Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci 86:131\u2013141","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1789_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.ASN.0000032548.18973.0F","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134\u2013141","journal-title":"J Am Soc Nephrol"},{"key":"1789_CR8","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000088293","volume":"102","author":"M Odamaki","year":"2006","unstructured":"Odamaki M, Furuya R, Kinumura Y, Ikegaya N, Kumagai H (2006) Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients. Nephron Clin Pract 102:c8\u2013c13","journal-title":"Nephron Clin Pract"},{"key":"1789_CR9","doi-asserted-by":"crossref","first-page":"c18","DOI":"10.1159\/000085707","volume":"101","author":"W Ignacy","year":"2005","unstructured":"Ignacy W, Chudek J, Adamczak M, Funahashi T, Matsuzawa Y, Kokot F, Wiecek A (2005) Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease\u2013a follow-up study. Nephron Clin Pract 101:c18\u2013c24","journal-title":"Nephron Clin Pract"},{"key":"1789_CR10","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1681\/ASN.2006040331","volume":"17","author":"V Menon","year":"2006","unstructured":"Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ (2006) Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17:2599\u20132606","journal-title":"J Am Soc Nephrol"},{"key":"1789_CR11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/ndt\/gfn070","volume":"23","author":"M Rao","year":"2008","unstructured":"Rao M, Li L, Tighiouart H, Jaber BL, Pereira BJ, Balakrishnan VS (2008) Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant 23:2619\u20132628","journal-title":"Nephrol Dial Transplant"},{"key":"1789_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000221147","volume":"30","author":"JJ Diez","year":"2009","unstructured":"Diez JJ, Estrada P, Bajo MA, Fernandez-Reyes MJ, Grande C, del Peso G, Heras M, Molina A, Iglesias P, Sanchez-Villanueva R, Selgas R (2009) High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am J Nephrol 30:244\u2013252","journal-title":"Am J Nephrol"},{"key":"1789_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/ki.2009.200","volume":"76","author":"C Drechsler","year":"2009","unstructured":"Drechsler C, Krane V, Winkler K, Dekker FW, Wanner C (2009) Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int 76:567\u2013575","journal-title":"Kidney Int"},{"key":"1789_CR14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3181\/0806-RM-192","volume":"233","author":"KN Ealey","year":"2008","unstructured":"Ealey KN, Kaludjerovic J, Archer MC, Ward WE (2008) Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) 233:1546\u20131553","journal-title":"Exp Biol Med (Maywood)"},{"key":"1789_CR15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","volume":"35","author":"HS Berner","year":"2004","unstructured":"Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842\u2013849","journal-title":"Bone"},{"key":"1789_CR16","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl S1\u2013130"},{"key":"1789_CR17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s007740170002","volume":"19","author":"Y Nishizawa","year":"2001","unstructured":"Nishizawa Y, Nakamura T, Ohata H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Nakatsuka K, Miura M (2001) Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001). J Bone Miner Metab 19:338\u2013344","journal-title":"J Bone Miner Metab"},{"issue":"Suppl 6","key":"1789_CR18","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","volume":"11","author":"PD Delmas","year":"2000","unstructured":"Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11(Suppl 6):S2\u2013S17","journal-title":"Osteoporos Int"},{"key":"1789_CR19","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1373\/clinchem.2005.051524","volume":"51","author":"Y Maeno","year":"2005","unstructured":"Maeno Y, Inaba M, Okuno S, Yamakawa T, Ishimura E, Nishizawa Y (2005) Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients. Clin Chem 51:2312\u20132317","journal-title":"Clin Chem"},{"key":"1789_CR20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","volume":"77","author":"M Ueda","year":"2005","unstructured":"Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77:1130\u20131139","journal-title":"Life Sci"},{"key":"1789_CR21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/ajkd.2002.35692","volume":"40","author":"M Ueda","year":"2002","unstructured":"Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y (2002) Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 40:802\u2013809","journal-title":"Am J Kidney Dis"},{"key":"1789_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-08-0642","volume":"160","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2009) Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 160:265\u2013273","journal-title":"Eur J Endocrinol"},{"key":"1789_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2005-861483","volume":"37","author":"J Jurimae","year":"2005","unstructured":"Jurimae J, Rembel K, Jurimae T, Rehand M (2005) Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 37:297\u2013302","journal-title":"Horm Metab Res"},{"key":"1789_CR24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S8756-3282(03)00237-0","volume":"33","author":"L Lenchik","year":"2003","unstructured":"Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646\u2013651","journal-title":"Bone"},{"key":"1789_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2007.08.012","volume":"387","author":"XD Peng","year":"2008","unstructured":"Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY (2008) Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 387:31\u201335","journal-title":"Clin Chim Acta"},{"key":"1789_CR26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1210\/jc.2006-2097","volume":"92","author":"JB Richards","year":"2007","unstructured":"Richards JB, Valdes AM, Burling K, Perks UC, Spector TD (2007) Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 92:1517\u20131523","journal-title":"J Clin Endocrinol Metab"},{"key":"1789_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2265.2004.02081.x","volume":"61","author":"KC Huang","year":"2004","unstructured":"Huang KC, Cheng WC, Yen RF, Tsai KS, Tai TY, Yang WS (2004) Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents. Clin Endocrinol (Oxf) 61:204\u2013208","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1789_CR28","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1152\/ajpendo.00610.2006","volume":"293","author":"J Jurimae","year":"2007","unstructured":"Jurimae J, Jurimae T (2007) Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab 293:E42\u2013E47","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1789_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2265.2005.02312.x","volume":"63","author":"KW Oh","year":"2005","unstructured":"Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW (2005) The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 63:131\u2013138","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1789_CR30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1359\/JBMR.040107","volume":"19","author":"MD Kontogianni","year":"2004","unstructured":"Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546\u2013551","journal-title":"J Bone Miner Res"},{"key":"1789_CR31","first-page":"78","volume":"20","author":"B Ozkurt","year":"2009","unstructured":"Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Caglayan O, Tabak Y (2009) The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women. Eklem Hastalik Cerrahisi 20:78\u201384","journal-title":"Eklem Hastalik Cerrahisi"},{"key":"1789_CR32","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1093\/ndt\/gfp262","volume":"24","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Boutroy S, Guebre-Egziabher F, Juillard L, Drai J, Pelletier S, Richard M, Charrie A, Carlier MC, Chapurlat R, Laville M, Fouque D (2009) The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol Dial Transplant 24:3120\u20133125","journal-title":"Nephrol Dial Transplant"},{"key":"1789_CR33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","volume":"12","author":"Guideline Working Group, Japanese Society for Dialysis Therapy","year":"2008","unstructured":"Guideline Working Group, Japanese Society for Dialysis Therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 12:514\u2013525","journal-title":"Ther Apher Dial"},{"key":"1789_CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00198-004-1712-4","volume":"16","author":"S Okuno","year":"2005","unstructured":"Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y (2005) Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Osteoporos Int 16:501\u2013509","journal-title":"Osteoporos Int"},{"key":"1789_CR35","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","volume":"41","author":"B Gomez Jr","year":"1995","unstructured":"Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:1560\u20131566","journal-title":"Clin Chem"},{"key":"1789_CR36","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1210\/jc.85.11.4157","volume":"85","author":"Y Kumeda","year":"2000","unstructured":"Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85:4157\u20134161","journal-title":"J Clin Endocrinol Metab"},{"key":"1789_CR37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002239900497","volume":"63","author":"BJ Gertz","year":"1998","unstructured":"Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S (1998) Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int 63:102\u2013106","journal-title":"Calcif Tissue Int"},{"key":"1789_CR38","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/clinchem\/43.11.2058","volume":"43","author":"JD Clemens","year":"1997","unstructured":"Clemens JD, Herrick MV, Singer FR, Eyre DR (1997) Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43:2058\u20132063","journal-title":"Clin Chem"},{"key":"1789_CR39","first-page":"3","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"R Baron","year":"1999","unstructured":"Baron R (1999) Anatomy and ultrastructure of bone. In: Fravus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams, Philadelphia, pp 3\u201310"},{"key":"1789_CR40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00223-008-9206-6","volume":"84","author":"K Kohno","year":"2009","unstructured":"Kohno K, Inaba M, Okuno S, Maeno Y, Maekawa K, Yamakawa T, Ishimura E, Nishizawa Y (2009) Association of reduction in bone mineral density with mortality in male hemodialysis patients. Calcif Tissue Int 84:180\u2013185","journal-title":"Calcif Tissue Int"},{"key":"1789_CR41","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1681\/ASN.V1291921","volume":"12","author":"E Ishimura","year":"2001","unstructured":"Ishimura E, Okuno S, Kim M, Yamamoto T, Izumotani T, Otoshi T, Shoji T, Inaba M, Nishizawa Y (2001) Increasing body fat mass in the first year of hemodialysis. J Am Soc Nephrol 12:1921\u20131926","journal-title":"J Am Soc Nephrol"},{"key":"1789_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1359\/jbmr.070813","volume":"23","author":"LJ Zhao","year":"2008","unstructured":"Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17\u201329","journal-title":"J Bone Miner Res"},{"key":"1789_CR43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00223-010-9376-x","volume":"87","author":"M Frost","year":"2010","unstructured":"Frost M, Abrahamsen B, Nielsen TL, Frystyk J, Flyvbjerg A, Hagen C, Andersen M, Brixen K (2010) Adiponectin and peak bone mass in men: a cross-sectional, population-based study. Calcif Tissue Int 87:36\u201343","journal-title":"Calcif Tissue Int"},{"key":"1789_CR44","doi-asserted-by":"crossref","unstructured":"Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I (2005) Adiponectin increased bone mass by suppressing osteoclast and actiating osteoblast. Biochem Biophys Res Commun 331:520\u2013526","DOI":"10.1016\/j.bbrc.2005.03.210"},{"key":"1789_CR45","doi-asserted-by":"crossref","unstructured":"Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99\u2013109","DOI":"10.1016\/j.yexcr.2005.05.021"},{"key":"1789_CR46","doi-asserted-by":"crossref","unstructured":"Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648\u20131656","DOI":"10.1359\/jbmr.060707"},{"key":"1789_CR47","doi-asserted-by":"crossref","unstructured":"Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH (2010) Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta 411:771\u2013775","DOI":"10.1016\/j.cca.2010.02.064"},{"key":"1789_CR48","doi-asserted-by":"crossref","unstructured":"Wolf G (2003) Adiponectin: a regulator of energy homeostasis. Nutr Rev 61:290\u2013292","DOI":"10.1301\/nr.2003.aug.290-292"},{"key":"1789_CR49","doi-asserted-by":"crossref","unstructured":"Oh DK, Ciaraldi T, Henry RR (2007) Adiponectin in health and disease. Diabetes Obes metab 9:282\u2013289","DOI":"10.1111\/j.1463-1326.2006.00610.x"},{"key":"1789_CR50","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1359\/jbmr.090519","volume":"24","author":"MR Araneta","year":"2009","unstructured":"Araneta MR, von Muhlen D, Barrett-Connor E (2009) Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res 24:2016\u20132022","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1789-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1789-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T06:25:15Z","timestamp":1638685515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1789-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,17]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1789-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,17]]}}}